1. Home
  2. PAGS vs CELC Comparison

PAGS vs CELC Comparison

Compare PAGS & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PAGS

PagSeguro Digital Ltd.

HOLD

Current Price

$11.42

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo Celcuity Inc.

CELC

Celcuity Inc.

HOLD

Current Price

$107.90

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAGS
CELC
Founded
2006
2011
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
PAGS
CELC
Price
$11.42
$107.90
Analyst Decision
Buy
Strong Buy
Analyst Count
7
8
Target Price
$11.86
$100.13
AVG Volume (30 Days)
4.1M
796.0K
Earning Date
03-05-2026
11-12-2025
Dividend Yield
1.27%
N/A
EPS Growth
16.68
N/A
EPS
1.37
N/A
Revenue
$3,662,823,389.00
N/A
Revenue This Year
$14.75
N/A
Revenue Next Year
$5.68
N/A
P/E Ratio
$8.03
N/A
Revenue Growth
10.88
N/A
52 Week Low
$6.70
$7.58
52 Week High
$12.32
$120.32

Technical Indicators

Market Signals
Indicator
PAGS
CELC
Relative Strength Index (RSI) 59.26 49.74
Support Level $10.53 $103.92
Resistance Level $11.90 $111.00
Average True Range (ATR) 0.51 6.00
MACD -0.04 -1.04
Stochastic Oscillator 58.31 23.68

Price Performance

Historical Comparison
PAGS
CELC

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: